• Citer

Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer.

par Bergh, Jonas;Mariani, Gabriella;Cardoso, Fatima ;Liljegren, A.;Awada, Ahmad ;Vigano, L.;Huang, Xing ;Verkh, L.;Kern, Kenneth A;Giorgetti, C.;Gianni, Luca
Référence Breast, 21, 4, page (507-513)
Publication Publié, 2012-08

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer.
Auteur:	Bergh, Jonas; Mariani, Gabriella; Cardoso, Fatima; Liljegren, A.; Awada, Ahmad; Vigano, L.; Huang, Xing; Verkh, L.; Kern, Kenneth A; Giorgetti, C.; Gianni, Luca
Informations sur la publication:	Breast, 21, 4, page (507-513)
Statut de publication:	Publié, 2012-08
Sujet CREF:	Cancérologie
Mots-clés:	Advanced breast cancer
	Docetaxel
	Sunitinib
	Tyrosine kinase inhibitor
MeSH keywords:	Adult
	Aged
	Antineoplastic Agents -- administration & dosage -- adverse effects -- pharmacokinetics
	Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics -- therapeutic use
	Breast Neoplasms -- drug therapy -- metabolism
	Carcinoma, Ductal, Breast -- drug therapy -- metabolism
	Carcinoma, Lobular -- drug therapy -- metabolism
	Drug Administration Schedule
	Drug Interactions
	Feasibility Studies
	Female
	Humans
	Indoles -- administration & dosage -- adverse effects -- pharmacokinetics
	Middle Aged
	Neoplasm Recurrence, Local -- drug therapy
	Pyrroles -- administration & dosage -- adverse effects -- pharmacokinetics
	Receptor, erbB-2 -- metabolism
	Taxoids -- administration & dosage -- adverse effects -- pharmacokinetics
	Treatment Outcome
Note générale:	Clinical Trial
	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0960-9776
	info:doi/10.1016/j.breast.2012.01.012
	info:pii/S0960-9776(12)00018-5
	info:scp/84863874195
	info:pmid/22336056